文献速递中医内科中药与中成药合理使用

葛枳解酒汤通过多信号通路改善酒精性肝病

Ge-Zhi-Jie-Jiu decoction alleviates alcoholic liver disease through multiple signaling pathways.
PubMed 文献 · J Ethnopharmacol · 2024-09-21

该研究采用UPLC-Q-Orbitrap HRMS、HPLC指纹图谱和LC-MS鉴定葛枳解酒汤成分,结合网络药理学与分子对接预测靶点,并在急性酒精性肝损伤小鼠模型中验证。结果显示该方可能通过促进酒精代谢、抑制氧化应激、炎症和凋亡(Nrf2/Keap1/HO-1和MAPK通路)及减少肝脂质蓄积(PPARα通路)发挥抗酒精性肝病作用。

要点

  • 葛枳解酒汤主要成分为有机酸、黄酮和异黄酮类。
  • 葛根素、大豆苷元等6种成分可作为该方指标成分。
  • 该方可能通过多通路改善酒精性肝损伤。

核心结论

  • 葛枳解酒汤具有显著的抗酒精性肝病药效,其机制涉及多信号通路。
  • 该研究为葛枳解酒汤作为抗酒精性肝病药物开发提供了实验基础。

研究设计与样本

  • 采用UPLC-Q-Orbitrap HRMS、HPLC指纹图谱和LC-MS进行成分鉴定与质量控制。
  • 运用网络药理学和分子对接预测药理成分与分子机制。
  • 建立急性酒精性肝损伤小鼠模型,通过H&E、油红O、TUNEL染色、RT-qPCR、Western blot和分子对接验证机制。

主要发现

  • 葛枳解酒汤主要成分包括有机酸、黄酮和异黄酮类。
  • 葛根素、大豆苷元、黄豆黄素、芒柄花苷、槲皮素和鸢尾黄素可作为指标成分。
  • 该方可能通过酒精代谢酶促进酒精代谢。
  • 该方可能通过Nrf2/Keap1/HO-1和MAPK信号通路抑制氧化应激、炎症和凋亡。
  • 该方可能通过PPARα信号通路减轻肝脏脂质蓄积。

临床怎么用

  • 葛枳解酒汤可作为酒精性肝病的潜在中药复方进行进一步开发研究。
  • 其多成分、多通路作用特点提示临床可用于酒精性肝损伤的辅助干预。

局限性

  • 研究仅基于急性酒精性肝损伤小鼠模型,缺乏长期或慢性模型验证。
  • 药理机制主要依赖网络药理学预测和分子对接,需进一步实验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Alcoholic liver disease (ALD) is a growing public health concern caused by excessive alcohol consumption, but effective treatments are limited. Ge-Zhi-Jie-Jiu decoction (JJY) is a modified traditional Chinese herbal remedy that aims to alleviate ALD. This formula contains various components such as Ge Hua, Ge Gen, Zhi Ju Zi, and other medicinal-food herbs. However, the specific pharmacotherapeutic compounds of JJY and its pharmacological mechanisms remain unclear. AIM OF THE STUDY: This study aimed to elucidate the molecular mechanism and pharmacodynamic basis of JJY in treating ALD. MATERIALS AND METHODS: UPLC-Q-Orbitrap HRMS, HPLC fingerprinting, and LC-MS techniques were used for the composition identification and quality control of JJY. The pharmacological components and molecular mechanisms of JJY in anti-ALD were then predicted using network pharmacology and molecular docking approaches. Ultimately, an acute alcoholic liver injury mouse model was developed, and the potential mechanisms were verified by hematoxylin-eosin (H&E), Oil Red O, and TUNEL staining, real-time fluorescence quantitative PCR (RT-qPCR), Western blot (WB) and molecular docking analysis. RESULTS: The results showed that the main components of JJY are organic acids, flavonoids, and isoflavonoids, in which puerarin, daidzein, glycitein, ononin, quercetin, and tectorigenin can be used as the indicator components of JJY. In addition, JJY might ameliorate ALD through several pathways, including potentially promoting alcohol metabolism via alcohol-metabolizing enzymes, and possibly inhibiting oxidative stress, inflammation and apoptosis via the Nrf2/Keap1/HO-1 and MAPK signaling pathways. Furthermore, JJY may also alleviated hepatic lipid accumulation through the PPARα signaling pathway. CONCLUSIONS: JJY has significant anti-ALD efficacy with multiple mechanisms. This study offers a solid experimental foundation for JJY's development as a medicine with anti-ALD characteristics and elucidates its probable active components.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Chen Y, Gao T, Bai J, et al. Ge-Zhi-Jie-Jiu decoction alleviates alcoholic liver disease through multiple signaling pathways. J Ethnopharmacol. 2024. PMID: 39313140. doi:10.1016/j.jep.2024.118840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。